Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species
出版年份 2018 全文链接
标题
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 19, Issue 9, Pages 971-977
出版商
Informa UK Limited
发表日期
2018-06-23
DOI
10.1080/14656566.2018.1476490
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
- (2018) John E Edwards et al. CLINICAL INFECTIOUS DISEASES
- VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans
- (2017) Timothy J Break et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural analyses ofCandida albicanssterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
- (2017) Tatiana Y. Hargrove et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
- (2017) Maiken Cavling Arendrup et al. JOURNAL OF INFECTIOUS DISEASES
- Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
- (2017) Matthew W McCarthy et al. JOURNAL OF INFECTIOUS DISEASES
- Recurrent vulvovaginal candidiasis
- (2016) Jack D. Sobel AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates
- (2016) Somanon Bhattacharya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds
- (2016) W. A. Schell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Oral Carriage of Non- albicans Candida spp. among HIV-infected individuals
- (2016) Martha F. Mushi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The development of fluconazole resistance in Candida albicans – an example of microevolution of a fungal pathogen
- (2016) Joachim Morschhäuser JOURNAL OF MICROBIOLOGY
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
- (2016) Kelley R. Healey et al. Nature Communications
- Fluconazole-Resistant Candida albicans Vulvovaginitis
- (2016) Dror Marchaim et al. OBSTETRICS AND GYNECOLOGY
- Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis
- (2015) E. P. Garvey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model
- (2014) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents
- (2014) F. Choukri et al. JOURNAL DE MYCOLOGIE MEDICALE
- Investigation of the Expression Levels of Efflux Pumps in Fluconazole-Resistant Candida albicans Isolates
- (2014) Sinem GÜLAT et al. MIKROBIYOLOJI BULTENI
- Vulvovaginalcandidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression
- (2014) Jie-Yu Zhang et al. MYCOSES
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence
- (2011) Christos Iavazzo et al. JOURNAL OF WOMENS HEALTH
- Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights
- (2010) Melissa A. Kennedy et al. Current Infectious Disease Reports
- Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)
- (2008) Gilbert Donders et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans
- (2008) R. Manoharlal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in the multi-drug resistance regulatorMRR1, followed by loss of heterozygosity, are the main cause ofMDR1overexpression in fluconazole-resistantCandida albicansstrains
- (2008) Nico Dunkel et al. MOLECULAR MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search